Rethinking the Risk Evaluation and Mitigation Strategies (REMS) Program: Moving Toward Rigorous Evaluation of the FDA's Drug Safety Programs.
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.